Table 4 Antimycotic activity of the suppositories using Zone of inhibition (mm)
Organisms | Concentration (mg/ml) | CBC 1 | CBC 2 | CBC 3 | CBC 4 | CCB | CPEG | CBT20C | CBS20C | CBSC | CBT20S20C | Tioconazole (0.7Â mg/ml) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Candida albicans | 2.5 | 0.0 ± 0.0 | 10.0 ± 0.0 | 10.0 ± 0.0 | 11.0 ± 1.4 | 14.0 ± 0.0 | 14.0 ± 0.0 | 10.5 ± 0.7 | 12.0 ± 2.8 | 11.0 ± 1.4 | 12.0 ± 2.8 | 30.0 ± 0.0 |
5.0 | 12.0 ± 2.8 | 12.0 ± 0.0 | 14.0 ± 0.0 | 15.0 ± 1.4 | 17.0 ± 1.4 | 17.0 ± 1.4 | 14.0 ± 0.0 | 16.0 ± 2.8 | 15.0 ± 0.0 | 14.0 ± 2.8 | ||
10.0 | 13.0 ± 1.4 | 14.0 ± 0.0 | 17.0 ± 1.4 | 18.0 ± 0.0 | 19.0 ± 1.4 | 20.0 ± 0.0 | 17.0 ± 1.4 | 19.0 ± 1.4 | 17.0 ± 1.4 | 17.0 ± 1.4 | ||
20.0 | 15.0 ± 1.4 | 17.0 ± 1.4 | 19.0 ± 1.4 | 21.0 ± 1.4 | 23.0 ± 1.4 | 24.0 ± 0.0 | 19.0 ± 1.4 | 22.0 ± 2.8 | 19.0 ± 1.4 | 20.0 ± 0.0 | ||
Candida tropicalis | 2.5 | 0.0 ± 0.0 | 0.0 ± 0.0 | 10.0 ± 0.0 | 11.0 ± 1.4 | 13.0 ± 1.4 | 11.0 ± 1.4 | 10.0 ± 0.0 | 11.0 ± 1.4 | 10.0 ± 0.0 | 10.0 ± 0.0 | 30.0 ± 0.0 |
5.0 | 10.0 ± 0.0 | 10.0 ± 0.0 | 12.0 ± 0.0 | 15.0 ± 1.4 | 15.0 ± 1.4 | 14.0 ± 0.0 | 14.0 ± 0.0 | 15.0 ± 1.4 | 13.0 ± 1.4 | 13.0 ± 1.4 | ||
10.0 | 12.0 ± 0.0 | 12.0 ± 0.0 | 14.0 ± 0.0 | 17.0 ± 1.4 | 18.0 ± 0.0 | 14.0 ± 0.0 | 14.0 ± 0.0 | 15.0 ± 1.4 | 13.0 ± 1.4 | 13.0 ± 1.4 | ||
20.0 | 14.0 ± 0.0 | 15.0 ± 1.4 | 17.0 ± 1.4 | 19.0 ± 1.4 | 19.0 ± 1.4 | 20.0 ± 0.0 | 21.0 ± 1.4 | 19.0 ± 1.4 | 20.0 ± 0.0 | 20.0 ± 0.0 | ||
Candida krusei | 2.5 | 0.0 ± 0.0 | 0.0 ± 0.0 | 11.0 ± 1.4 | 13.0 ± 1.4 | 13.0 ± 1.4 | 13.0 ± 1.4 | 10.0 ± 0.0 | 13.0 ± 4.2 | 10.0 ± 0.0 | 10.0 ± 0.0 | 30.0 ± 2.8 |
5.0 | 11.0 ± 1.4 | 12.0 ± 2.8 | 15.0 ± 1.4 | 16.0 ± 2.8 | 15.0 ± 1.4 | 13.0 ± 1.4 | 13.0 ± 1.4 | 17.0 ± 4.2 | 13.0 ± 1.4 | 14.0 ± 0.0 | ||
10.0 | 14.0 ± 0.0 | 12.0 ± 0.0 | 18.0 ± 0.0 | 19.0 ± 1.4 | 17.0 ± 1.4 | 19.0 ± 1.4 | 17.0 ± 1.4 | 21.0 ± 4.2 | 16.0 ± 0.0 | 17.0 ± 1.4 | ||
20.0 | 16.0 ± 0.0 | 15.0 ± 1.4 | 19.0 ± 1.4 | 23.0 ± 1.4 | 21.0 ± 1.4 | 23.0 ± 1.4 | 20.0 ± 0.0 | 24.0 ± 2.8 | 18.0 ± 0.0 | 19.0 ± 1.4 |